Dr. Paula Pohlmann, MD, PhD
Claim this profileLombardi Cancer Center / Georgetown University Medical Center
Studies Breast Cancer
Studies Tumors
10 reported clinical trials
18 drugs studied
Area of expertise
1Breast Cancer
Stage IV
HER2 positive
Stage III
2Tumors
Stage IV
Stage III
HER2 positive
Affiliated Hospitals
Clinical Trials Paula Pohlmann, MD, PhD is currently running
New Treatments
for Metastatic Breast Cancer
This trial is testing different medicines or combinations of medicines to treat cancer. It focuses on patients with certain solid tumors, including breast cancer. The study aims to find the safest and most effective dose and then tests that dose on more patients to see if it works. Dinaciclib is being evaluated for its potential in combination therapies for breast cancer.
Recruiting1 award Phase 110 criteria
ORM-5029
for HER2-Positive Breast Cancer
This trial is testing a new drug called ORM-5029 in patients with advanced cancers that have the HER2 protein. The drug aims to find and attack these specific cancer cells. ORM-5029 is being tested for its ability to target HER2-positive cancer cells, a strategy previously explored with other drugs.
Recruiting1 award Phase 1
More about Paula Pohlmann, MD, PhD
Clinical Trial Related1 year of experience running clinical trials · Led 10 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Paula Pohlmann, MD, PhD has experience with
- Tucatinib
- Trastuzumab
- Fulvestrant
- Palbociclib
- Trastuzumab Deruxtecan
- T-DM1
Breakdown of trials Paula Pohlmann, MD, PhD has run
Breast Cancer
Tumors
Cervical Cancer
Uterine Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Paula Pohlmann, MD, PhD specialize in?
Paula Pohlmann, MD, PhD focuses on Breast Cancer and Tumors. In particular, much of their work with Breast Cancer has involved Stage IV patients, or patients who are HER2 positive.
Is Paula Pohlmann, MD, PhD currently recruiting for clinical trials?
Yes, Paula Pohlmann, MD, PhD is currently recruiting for 2 clinical trials in Washington District of Columbia. If you're interested in participating, you should apply.
Are there any treatments that Paula Pohlmann, MD, PhD has studied deeply?
Yes, Paula Pohlmann, MD, PhD has studied treatments such as Tucatinib, Trastuzumab, Fulvestrant.
What is the best way to schedule an appointment with Paula Pohlmann, MD, PhD?
Apply for one of the trials that Paula Pohlmann, MD, PhD is conducting.
What is the office address of Paula Pohlmann, MD, PhD?
The office of Paula Pohlmann, MD, PhD is located at: Lombardi Cancer Center / Georgetown University Medical Center, Washington, District of Columbia 20007 United States. This is the address for their practice at the Lombardi Cancer Center / Georgetown University Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.